Sacituzumab Govitecan
Drug · tier A · 8 trials (3 recruiting) · 9 publications · score 76.5
Mitomycin
Drug · tier A · 8 trials (1 recruiting) · 11 publications · score 76.0
Olaparib
Drug · tier A · 8 trials (3 recruiting) · 11 publications · score 75.0
Carboplatin
Drug · tier A · 8 trials (1 recruiting) · 17 publications · score 74.0
Nicotine
Drug · tier A · 8 trials (0 recruiting) · 19 publications · score 74.0
Vinorelbine
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 74.0
Gemcitabine
Drug · tier A · 8 trials (0 recruiting) · 17 publications · score 72.0
Oxaliplatin
Drug · tier A · 8 trials (3 recruiting) · 16 publications · score 70.5
Cisplatin
Drug · tier A · 8 trials (0 recruiting) · 17 publications · score 70.0
Bleomycin
Drug · tier A · 4 trials (1 recruiting) · 13 publications · score 62.0
Doxorubicin Hydrochloride
Drug · tier A · 8 trials (0 recruiting) · 5 publications · score 54.0
Talazoparib
Drug · tier A · 8 trials (0 recruiting) · 5 publications · score 51.5
Niraparib
Drug · tier A · 8 trials (1 recruiting) · 4 publications · score 51.0
Daunorubicin Hydrochloride
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 48.0
Paclitaxel Protein-Bound
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 46.0
Sirolimus
Drug · tier A · 8 trials (1 recruiting) · 5 publications · score 44.0
Rucaparib
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 38.0
Tamoxifen Citrate
Drug · tier A · 4 trials (0 recruiting) · 0 publications · score 33.5
Resveratrol
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 29.0
Dipyridamole
Drug · tier A · 0 trials (0 recruiting) · 4 publications · score 28.0
Mitoxantrone Hydrochloride
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 24.0
Riboflavin
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0
Research map, not treatment advice. Built 2026-10-07.